Straits Times Index
3,330.81 +0.80 (+0.02%) S&P 500
5,351.51 -2.52 (-0.05%) Dow
38,860.27 +52.94 (+0.14%) Nasdaq
17,181.26 -6.65 (-0.04%) Bitcoin USD
71,125.44 -381.16 (-0.53%) CMC Crypto 200
1,521.17 -3.64 (-0.24%)
EW Jun 2024 97.500 call
| Previous close | 0.0700 |
| Open | 0.0700 |
| Bid | 0.0500 |
| Ask | 0.2000 |
| Strike | 97.50 |
| Expiry date | 2024-06-21 |
| Day's range | 0.0700 - 0.0700 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.22k |
ZacksBD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
Business WireFive-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
NEW YORK, June 05, 2024--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve patients there were excellent clinical outcomes and valve durability irrespective of the patient’s annulus size or sex. These data were presented during the late-breaking clinical
Simply Wall St.Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
